<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000341450"><TermName>immunophenotyping</TermName><TermPronunciation>(IH-myoo-noh-FEE-noh-ty-ping)</TermPronunciation><TermDefinition><DefinitionText>A process used to identify cells, based on the types of antigens or markers on the surface of the cell. This process is used to diagnose specific types of leukemia and lymphoma by comparing the cancer cells to normal cells of the immune system.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711177" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;immunophenotyping&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711178" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inmunofenotipificación&quot;" language="es" id="_4"/><SpanishTermName>inmunofenotipificación</SpanishTermName><SpanishTermDefinition><DefinitionText>Proceso utilizado para identificar células según los tipos de antígenos o marcadores de la superficie de la célula. Este proceso se usa para diagnosticar tipos específicos de leucemia y linfoma por medio de la comparación de las células cancerosas con las células normales del sistema inmunitario.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-10-25</DateFirstPublished></GlossaryTerm>
